148 related articles for article (PubMed ID: 36897780)
1. Source of nicotinamide governs its metabolic fate in cultured cells, mice, and humans.
Dutta T; Kapoor N; Mathew M; Chakraborty SS; Ward NP; Prieto-Farigua N; Falzone A; DeLany JP; Smith SR; Coen PM; DeNicola GM; Gardell SJ
Cell Rep; 2023 Mar; 42(3):112218. PubMed ID: 36897780
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of Allosteric Modulation of Nicotinamide Phosphoribosyltransferase to Elevate Cellular NAD
Ratia KM; Shen Z; Gordon-Blake J; Lee H; Laham MS; Krider IS; Christie N; Ackerman-Berrier M; Penton C; Knowles NG; Musku SR; Fu J; Velma GR; Xiong R; Thatcher GRJ
Biochemistry; 2023 Feb; 62(4):923-933. PubMed ID: 36746631
[TBL] [Abstract][Full Text] [Related]
3. Structural insights into Xanthomonas campestris pv. campestris NAD
Xu G; Ma J; Fang Q; Peng Q; Jiao X; Hu W; Zhao Q; Kong Y; Liu F; Shi X; Tang DJ; Tang JL; Ming Z
Commun Biol; 2024 Mar; 7(1):255. PubMed ID: 38429435
[TBL] [Abstract][Full Text] [Related]
4. Nicotinamide phosphoribosyltransferase (Nampt) affects the lineage fate determination of mesenchymal stem cells: a possible cause for reduced osteogenesis and increased adipogenesis in older individuals.
Li Y; He X; Li Y; He J; Anderstam B; Andersson G; Lindgren U
J Bone Miner Res; 2011 Nov; 26(11):2656-64. PubMed ID: 21812028
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, Optimization, and Structure-Activity Relationships of Nicotinamide Phosphoribosyltransferase (NAMPT) Positive Allosteric Modulators (N-PAMs).
Shen Z; Ratia K; Krider I; Ackerman-Berrier M; Penton C; Musku SR; Gordon-Blake JM; Laham MS; Christie N; Ma N; Fu J; Xiong R; Courey JM; Velma GR; Thatcher GRJ
J Med Chem; 2023 Dec; 66(24):16704-16727. PubMed ID: 38096366
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of the effects of nicotinamide phosphoribosyltransferase induction on the rates of NAD+ synthesis and breakdown in mammalian cells using stable isotope-labeling combined with mass spectrometry.
Hara N; Osago H; Hiyoshi M; Kobayashi-Miura M; Tsuchiya M
PLoS One; 2019; 14(3):e0214000. PubMed ID: 30875389
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of nicotinamide phosphoribosyltransferase and increase of NAD+ levels by glucose restriction extend replicative lifespan of human fibroblast Hs68 cells.
Yang NC; Song TY; Chang YZ; Chen MY; Hu ML
Biogerontology; 2015 Feb; 16(1):31-42. PubMed ID: 25146190
[TBL] [Abstract][Full Text] [Related]
8. Supplementation of nicotinic acid with NAMPT inhibitors results in loss of in vivo efficacy in NAPRT1-deficient tumor models.
O'Brien T; Oeh J; Xiao Y; Liang X; Vanderbilt A; Qin A; Yang L; Lee LB; Ly J; Cosino E; LaCap JA; Ogasawara A; Williams S; Nannini M; Liederer BM; Jackson P; Dragovich PS; Sampath D
Neoplasia; 2013 Dec; 15(12):1314-29. PubMed ID: 24403854
[TBL] [Abstract][Full Text] [Related]
9. Nicotinamide is an inhibitor of SIRT1 in vitro, but can be a stimulator in cells.
Hwang ES; Song SB
Cell Mol Life Sci; 2017 Sep; 74(18):3347-3362. PubMed ID: 28417163
[TBL] [Abstract][Full Text] [Related]
10. Drug discovery targeting nicotinamide phosphoribosyltransferase (NAMPT): Updated progress and perspectives.
Wen F; Gui G; Wang X; Ye L; Qin A; Zhou C; Zha X
Bioorg Med Chem; 2024 Feb; 99():117595. PubMed ID: 38244254
[TBL] [Abstract][Full Text] [Related]
11. Nicotinamide reprograms adipose cellular metabolism and increases mitochondrial biogenesis to ameliorate obesity.
Luo C; Yang C; Wang X; Chen Y; Liu X; Deng H
J Nutr Biochem; 2022 Sep; 107():109056. PubMed ID: 35609856
[TBL] [Abstract][Full Text] [Related]
12. Identification of structural determinants of nicotinamide phosphoribosyl transferase (NAMPT) activity and substrate selectivity.
Houry D; Raasakka A; Ferrario E; Niere M; Bifulco E; Kursula P; Ziegler M
J Struct Biol; 2023 Sep; 215(3):108004. PubMed ID: 37495196
[TBL] [Abstract][Full Text] [Related]
13. NAMPT in regulated NAD biosynthesis and its pivotal role in human metabolism.
Burgos ES
Curr Med Chem; 2011; 18(13):1947-61. PubMed ID: 21517777
[TBL] [Abstract][Full Text] [Related]
14. DNMT3A mutation promotes leukemia development through NAM-NAD metabolic reprogramming.
Yang X; Wang X; Yang Y; Li Z; Chen Y; Shang S; Wang Y
J Transl Med; 2023 Jul; 21(1):481. PubMed ID: 37464424
[TBL] [Abstract][Full Text] [Related]
15. Channeling Nicotinamide Phosphoribosyltransferase (NAMPT) to Address Life and Death.
Velma GR; Krider IS; Alves ETM; Courey JM; Laham MS; Thatcher GRJ
J Med Chem; 2024 Apr; 67(8):5999-6026. PubMed ID: 38580317
[TBL] [Abstract][Full Text] [Related]
16. Bacteria Boost Mammalian Host NAD Metabolism by Engaging the Deamidated Biosynthesis Pathway.
Shats I; Williams JG; Liu J; Makarov MV; Wu X; Lih FB; Deterding LJ; Lim C; Xu X; Randall TA; Lee E; Li W; Fan W; Li JL; Sokolsky M; Kabanov AV; Li L; Migaud ME; Locasale JW; Li X
Cell Metab; 2020 Mar; 31(3):564-579.e7. PubMed ID: 32130883
[TBL] [Abstract][Full Text] [Related]
17. Nicotinamide Metabolism Modulates the Proliferation/Differentiation Balance and Senescence of Human Primary Keratinocytes.
Tan CL; Chin T; Tan CYR; Rovito HA; Quek LS; Oblong JE; Bellanger S
J Invest Dermatol; 2019 Aug; 139(8):1638-1647.e3. PubMed ID: 30776433
[TBL] [Abstract][Full Text] [Related]
18. Nicotinamide phosphoribosyltransferase/visfatin does not catalyze nicotinamide mononucleotide formation in blood plasma.
Hara N; Yamada K; Shibata T; Osago H; Tsuchiya M
PLoS One; 2011; 6(8):e22781. PubMed ID: 21826208
[TBL] [Abstract][Full Text] [Related]
19. Nicotinamide Improves Aspects of Healthspan, but Not Lifespan, in Mice.
Mitchell SJ; Bernier M; Aon MA; Cortassa S; Kim EY; Fang EF; Palacios HH; Ali A; Navas-Enamorado I; Di Francesco A; Kaiser TA; Waltz TB; Zhang N; Ellis JL; Elliott PJ; Frederick DW; Bohr VA; Schmidt MS; Brenner C; Sinclair DA; Sauve AA; Baur JA; de Cabo R
Cell Metab; 2018 Mar; 27(3):667-676.e4. PubMed ID: 29514072
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiota severely hampers the efficacy of NAD-lowering therapy in leukemia.
ElMokh O; Matsumoto S; Biniecka P; Bellotti A; Schaeuble K; Piacente F; Gallart-Ayala H; Ivanisevic J; Stamenkovic I; Nencioni A; Nahimana A; Duchosal MA
Cell Death Dis; 2022 Apr; 13(4):320. PubMed ID: 35396381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
